These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26719882)

  • 1. SDHB-Deficient Cancers: The Role of Mutations That Impair Iron Sulfur Cluster Delivery.
    Saxena N; Maio N; Crooks DR; Ricketts CJ; Yang Y; Wei MH; Fan TW; Lane AN; Sourbier C; Singh A; Killian JK; Meltzer PS; Vocke CD; Rouault TA; Linehan WM
    J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26719882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability.
    Lehtonen HJ; Mäkinen MJ; Kiuru M; Laiho P; Herva R; van Minderhout I; Hogendoorn PC; Cornelisse C; Devilee P; Launonen V; Aaltonen LA
    Int J Cancer; 2007 Sep; 121(6):1386-9. PubMed ID: 17520677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Succinate dehydrogenase B-deficient renal cell carcinoma: A case report with novel germline mutation.
    Iwashita H; Okudela K; Matsumura M; Yamanaka S; Sawazumi T; Enaka M; Udaka N; Miyake A; Hibiya T; Miyake N; Matsumoto N; Makiyama K; Yao M; Nagashima Y; Ohashi K
    Pathol Int; 2017 Nov; 67(11):585-589. PubMed ID: 28960644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-Causing SDHAF1 Mutations Impair Transfer of Fe-S Clusters to SDHB.
    Maio N; Ghezzi D; Verrigni D; Rizza T; Bertini E; Martinelli D; Zeviani M; Singh A; Carrozzo R; Rouault TA
    Cell Metab; 2016 Feb; 23(2):292-302. PubMed ID: 26749241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
    Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
    Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TET-Mediated Hypermethylation Primes SDH-Deficient Cells for HIF2α-Driven Mesenchymal Transition.
    Morin A; Goncalves J; Moog S; Castro-Vega LJ; Job S; Buffet A; Fontenille MJ; Woszczyk J; Gimenez-Roqueplo AP; Letouzé E; Favier J
    Cell Rep; 2020 Mar; 30(13):4551-4566.e7. PubMed ID: 32234487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Succinate dehydrogenase (SDH)-deficient renal cell carcinoma].
    Agaimy A
    Pathologe; 2016 Mar; 37(2):144-52. PubMed ID: 26979428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP).
    Ricketts CJ; Killian JK; Vocke CD; Wang Y; Merino MJ; Meltzer PS; Linehan WM
    PLoS One; 2022; 17(12):e0278108. PubMed ID: 36455002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
    Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
    BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of succinate dehydrogenase-deficient renal cell carcinoma with focus on clinical and pathobiological aspects.
    Kuroda N; Yorita K; Nagasaki M; Harada Y; Ohe C; Jeruc J; Raspollini MR; Michal M; Hes O; Amin MB
    Pol J Pathol; 2016 Mar; 67(1):3-7. PubMed ID: 27179267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer.
    Aggarwal RK; Luchtel RA; Machha V; Tischer A; Zou Y; Pradhan K; Ashai N; Ramachandra N; Albanese JM; Yang JI; Wang X; Aluri S; Gordon S; Aboumohamed A; Gartrell BA; Hafizi S; Pullman J; Shenoy N
    Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34551979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Succinate Dehydrogenase-Deficient Renal Cell Carcinoma: A Short Review.
    Wang G; Rao P
    Arch Pathol Lab Med; 2018 Oct; 142(10):1284-1288. PubMed ID: 30281364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
    Gill AJ
    Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a signaling axis HIF-1α/microRNA-210/ISCU independent of SDH mutation that defines a subgroup of head and neck paragangliomas.
    Merlo A; de Quiros SB; Secades P; Zambrano I; Balbín M; Astudillo A; Scola B; Arístegui M; Suarez C; Chiara MD
    J Clin Endocrinol Metab; 2012 Nov; 97(11):E2194-200. PubMed ID: 22977270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma.
    Vanharanta S; Buchta M; McWhinney SR; Virta SK; Peçzkowska M; Morrison CD; Lehtonen R; Januszewicz A; Järvinen H; Juhola M; Mecklin JP; Pukkala E; Herva R; Kiuru M; Nupponen NN; Aaltonen LA; Neumann HP; Eng C
    Am J Hum Genet; 2004 Jan; 74(1):153-9. PubMed ID: 14685938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive/retained SDHB immunostaining in renal cell carcinomas associated to germline SDHB-deficiency: case report.
    Ugarte-Camara M; Fernandez-Prado R; Lorda I; Rossello G; Gonzalez-Enguita C; Cannata-Ortiz P; Ortiz A
    Diagn Pathol; 2019 May; 14(1):42. PubMed ID: 31092265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.
    Pollard PJ; El-Bahrawy M; Poulsom R; Elia G; Killick P; Kelly G; Hunt T; Jeffery R; Seedhar P; Barwell J; Latif F; Gleeson MJ; Hodgson SV; Stamp GW; Tomlinson IP; Maher ER
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4593-8. PubMed ID: 16954163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SDHB loss predicts malignancy in pheochromocytomas/sympathethic paragangliomas, but not through hypoxia signalling.
    Blank A; Schmitt AM; Korpershoek E; van Nederveen F; Rudolph T; Weber N; Strebel RT; de Krijger R; Komminoth P; Perren A
    Endocr Relat Cancer; 2010 Dec; 17(4):919-28. PubMed ID: 20702724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations.
    Lima J; Feijão T; Ferreira da Silva A; Pereira-Castro I; Fernandez-Ballester G; Máximo V; Herrero A; Serrano L; Sobrinho-Simões M; Garcia-Rostan G
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4853-64. PubMed ID: 17848412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
    Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
    JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.